Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 32.0B | 44.7B | 32.4B | 30.7B |
Cost of revenue | 25.4B | 32.8B | 25.2B | 22.2B |
Gross profit | 6.6B | 11.9B | 7.2B | 8.6B |
Operating expense | ||||
Research & development | — | 862.6M | 931.2M | 1.1B |
Selling general and admin | 3.8B | 878.6M | 727.6M | 708.9M |
Other operating expenses | — | 95.8M | 173.6M | 96.7M |
Operating income | 6.6B | 8.2B | 4.0B | 5.1B |
Non operating interest income | ||||
Income | — | 251.2M | 306.0M | 516.9M |
Expense | — | 1.4B | 2.3B | 2.2B |
Other income expense | — | — | — | — |
Pretax income | 944.1M | 9.3B | 1.1B | 4.0B |
Tax provision | -748.4M | -278.8M | -1.9B | -371.9M |
Net income | 1.7B | 9.5B | 2.9B | 4.4B |
Basic EPS | 27.0 | — | 45 | 66 |
Diluted EPS | 27.0 | — | 45 | 66 |
Basic average shares | — | — | 65.6M | 66.1M |
Diluted average shares | — | — | 65.6M | 66.1M |
EBITDA | 6.6B | 13.6B | 6.2B | 8.8B |
Net income from continuing op. | — | 9.5B | 2.9B | 4.4B |
Minority interests | 82.4M | -161.8M | 6.2M | -1.9M |
Preferred stock dividends | — | — | — | — |